Temperatures hit 82 degrees in Washington, D.C., Wednesday, one of the highest readings the city has ever experienced in February. And for the second day in a row, Boston set a high-temperature record for a February day: 71 degrees. In New York’s Central Park, the temperature hit 78 degrees, the highest ever recorded in February. The milestone shattered the record for Feb. 21, which had previously stood at 68 degrees, back in 1930. “We’re not breaking daily records, we’re breaking all-time temperature records,” said Andrew Freedman, senior science editor of Mashable. According to Freedman, part of the explanation lies in an unusual disturbance of the polar vortex, which in the past week has split in two, producing two distinct cold waves across the globe. “You had one portion of it moving into the Western U.S. and Canada, while at the same time one portion of it moved into Europe and Eurasia,” Freedman said. “So those are the two cold spots in the Northern Hemisphere right now. And in the eastern U.S., suddenly we had this incredible warm-up today and on Tuesday.” Freedman explained the split in the polar vortex. “Normally, you have this circulation of fast winds in the upper levels of the atmosphere over the Arctic. Usually, it stays put; it behaves well.” But this year the planet experienced what Freedman called a Sudden Stratospheric Warming event. “You had energy from the lower atmosphere go up to the upper atmosphere and sort of knocked it off balance.” Freedman added that climate change is also contributing to the record temperatures on the East Coast. “It’s easier for us to set these high-temperature records as the climate continues to warm,” he said. “That's the bottom line climate message overall.” And as for what’s ahead, well, Freedman said, on Thursday, “It’s going to snow in Boston.” Read more at [Mashable](https://mashable.com/2018/02/15/polar-vortex-split-stratospheric-warming-snow-cold-europe-us/).

Share:
More In Science
New BA.2 Variant Predicted to Boost Covid Cases in U.S.
A subvariant of the omicron COVID-19 variant called BA.2 is causing an outbreak overseas. Now, some health experts worry it could also lead to an increase in COVID-19 cases in the U.S. Dr. Amesh Adalja, infectious disease specialist and senior scholar at Johns Hopkins Center for Health Security, joins Cheddar News to discuss.
Green Battery Materials Maker Nouveau Monde Graphite Aims to Power Energy Revolution
Nouveau Monde Graphite says it wants to power the sustainable energy revolution. The Canadian company is developing carbon-neutral battery materials to serve the growing EV and cleantech markets and is doing so via a mining and manufacturing operation in Quebec. Eric Desaulniers, founder, president & CEO of Nouveau Monde Graphite, joins Cheddar News' Closing Bell to discuss.
There's A New Subvariant. How Concerned Should We Be?
Health experts are warning an even more contagious subvariant of Omicron, known as BA.2, could soon lead to another surge in Covid cases here in the U.S. The variant has already driven cases to skyrocket in China and Europe, which has historically served as a preview to the pattern the U.S. has seen throughout the pandemic. This comes at a time when protection from booster shots is waning for most people who got them. Dr. Jen Caudle, Family Physician & Associate Professor at Rowan University, explains what we can do to protect ourselves against the new variant and how we should act as warnings of another surge rise.
Cresco Labs to Become the Largest U.S. Cannabis Company by Sales With Columbia Care Acquisition
Cannabis producer Cresco Labs is acquiring rival Columbia Care in a $2 billion all-stock deal, creating the largest U.S. cannabis company by sales. The deal, which is expected to close in the fourth quarter of 2022, is one of the biggest in the industry's history and would make Cresco the dominant player in a market projected to reach $46 billion in revenue by 2026. Charlie Bachtell, CEO of Cresco Labs, joins Cheddar News' Closing Bell to discuss.
Breaking Down Moderna Seeking COVID Vaccine Approval for Kids Under 6
Moderna announced it's seeking emergency use approval for its COVID-19 vaccine from the FDA for children under 6 years old. A former FDA associate commissioner and the president and co-founder of the Center for Medicine in the Public Interest (CMPI) Peter Pitts joined Cheddar News to talk about the timeline, benefits, and risks that come with the approval of the vaccine. "We want to protect their parents and their grandparents and their caregivers and their daycare providers, so it's all about protecting not just the kids but all around the people that are surrounding those kids," he said.
Load More